| Monitoring PD-L1 expression on circulating tumor–associated cells in recurrent metastatic non–small-cell lung carcinoma predicts response to immunotherapy with radiation therapy JA Moran, DL Adams, MJ Edelman, P Lopez, J He, Y Qiao, T Xu, Z Liao, ... JCO precision oncology 6, e2200457, 2022 | 17 | 2022 |
| Sequential monitoring of PD-L1 on circulating stromal cells in blood predicts PFS in NSCLC patients undergoing immunotherapy after definitive chemoradiation DL Adams, A Augustyn, J He, Y Qiao, T Xu, ZX Liao, KJ Gardner, J Moran, ... J Clin Oncol 39 (15 SUPPL), 2021 | 2 | 2021 |
| Extracellular vesicles budding from stromal macrophages in the blood of metastatic non-small cell lung cancer patients correlates with poor survival JA Moran, SH Lin, MJ Edelman, P Lopez, J He, Y Qiao, T Xu, Z Liao, ... Cancer Research 83 (7_Supplement), 3310-3310, 2023 | 1 | 2023 |
| OA17. 06 The Predictive Value of PD-L1 levels on Circulating Stromal Cells in Unresectable Stage 3 NSCLC Treated with Chemoradiation S Lin, A Seo, T Xu, A Tsao, JV Heymach, Z Liao, JY Chang, KP Gardner, ... Journal of Thoracic Oncology 18 (11), S85, 2023 | | 2023 |
| Extracellular vesicles budding from stromal macrophages from the blood circulating in patients with metastatic non-small cell lung cancer to predict clinical outcomes. J Moran, DL Adams, MJ Edelman, P Lopez Bravo, T Xu, ZX Liao, ... Journal of Clinical Oncology 41 (16_suppl), e14547-e14547, 2023 | | 2023 |
| Monitoring PD-L1 expression on circulating stromal cells in blood predicts PFS and OS in patients with metastatic NSCLC treated with PD-L1/PD-1 immunotherapy. J Moran, DL Adams, P Lopez Bravo, J He, Y Qiao, T Xu, ZX Liao, ... Journal of Clinical Oncology 40 (16_suppl), 8535-8535, 2022 | | 2022 |
| Sequential Monitoring of PD-L1 on Circulating Tumor Stromal Cells Predicts Survival Outcomes for Unresectable Stage 3 NSCLC Treated With Immunotherapies After Definitive … SH Lin, A Augustyn, J He, Y Qiao, T Xu, Z Liao, KP Gardner, JA Moran, ... International Journal of Radiation Oncology, Biology, Physics 111 (3), S12, 2021 | | 2021 |
| Monitoring PD-L1 Expression on Circulating Stromal Cells in Blood Predicts PFS and OS in Metastatic NSCLC Patients Treated with PD-L1/PD-1 Immunotherapy JA Moran, DL Adams, P Lopez, J He, Y Qiao, T Xu, Z Liao, KP Gardner, ... | | |
